Skip to content
value.today

Medovex Corp.

🇺🇸 Atlanta, Georgia, USAHealth CareFounded 2013

Formerly SpineZ Corp.

Total raised
$10 M
3 rounds on record
Latest round
$3 M
Apr 2020
First round on record
Apr 2016
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Medovex Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2020$3 MNo. 3$2 to $10 million

Medovex Corp.: Raise no. 3, Apr 2020

Investors in this round

32 investors had bought by the notice of May 5, 2020: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Medovex Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$1,875
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Ann E. Miller · Executive Officer · Chief Operating Officer
  • Jeremy E. Daniel · Executive Officer · Chief Financial Officer
  • William E. Horne · Executive Officer, Director · Chief Executive Officer
  • Michael E. Yukowsky · Director
  • Raymond E. Monteleone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeremy Daniel, Cfo. Source: SEC Form D, newest notice filed May 5, 2020. Read the notice at the SEC.

equity, optionsSEC
Nov 2019$6 MNo. 2$2 to $10 million

Medovex Corp.: Raise no. 2, Nov 2019

Investors in this round

1 investor had bought by the notice of Nov 27, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Medovex Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $10 M offered; $4 M still to sell
Smallest investment taken
$6,000,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$200,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Ann E. Miller · Executive Officer · Chief Operating Officer
  • Jeremy E. Daniel · Executive Officer · Chief Financial Officer
  • William E. Horne · Executive Officer, Director · Chief Executive Officer
  • Michael E. Yurkowsky · Director
  • Raymond E. Monteleone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeremy Daniel, Cfo. Source: SEC Form D, newest notice filed Nov 27, 2019. Read the notice at the SEC.

equity, optionsSEC
Apr 2016$1 MNo. 1Under $2 million

Medovex Corp.: Raise no. 1, Apr 2016

Investors in this round

32 investors had bought by the notice of May 3, 2016: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Medovex Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
$100,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$167,764
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Charles Farrahar · Executive Officer · Secretary
  • Dennis Moon · Executive Officer · Senior Vice President
  • Jarrett Gorlin · Executive Officer, Director · Chief Executive Officer
  • Jeffery Wright · Executive Officer · Chief Financial Officer
  • Patrick Kullman · Executive Officer, Director · President and Chief Operating Officer
  • C.A. Hennies · Director
  • James Andrews · Director
  • John Blank · Director
  • John Thomas, Jr. · Director
  • Larry Papasan · Director · Co-Chairman
  • Randal Betz · Director
  • Scott Haufe · Director
  • Steve Gorlin · Director · Co-Chairman
  • Thomas Hills · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Laidlaw and Company (UK) Ltd. (CRD 119037) · London, United KingdomSold in all US states

Remarks in the notice

  • On the amounts: “The Company has completed the Offering.”

Signed by Jarrett Gorlin, Ceo. Source: SEC Form D, newest notice filed May 3, 2016. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medovex Corp. chose not to state its revenue in its newest notice of a funding round (May 2020).

    SEC Form D · May 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · May 2020

That is all the official record says: Medovex Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

3 named in official filings. Open an investor to see everything it has backed.

Investors in Medovex Corp.
InvestorKindAmountRoundRoleSource
Cfrs Investments, LLCFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2022)SEC Form 3
Fwhc Holdings, LLCOthernot statednot statedHeld Series D preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Hoa Capital LLCFund or asset managernot statednot statedHeld Series D preferred stock, 10% owner (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 32 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medovex Corp.
NameRoleNamed in
Ann E. MillerChief Operating OfficerMay 2020
Jeremy E. DanielChief Financial OfficerMay 2020
William E. HorneChief Executive OfficerMay 2020
Charles FarraharSecretaryMay 2016
Dennis MoonSenior Vice PresidentMay 2016
Jarrett GorlinChief Executive OfficerMay 2016
Jeffery WrightChief Financial OfficerMay 2016
Patrick KullmanPresident and Chief Operating OfficerMay 2016
Michael E. YukowskyDirectorMay 2020
Raymond E. MonteleoneDirectorMay 2020
William E. HorneChief Executive OfficerMay 2020
Michael E. YurkowskyDirectorNov 2019
C.A. HenniesDirectorMay 2016
James AndrewsDirectorMay 2016
Jarrett GorlinChief Executive OfficerMay 2016
John BlankDirectorMay 2016
John Thomas, Jr.DirectorMay 2016
Larry PapasanCo-ChairmanMay 2016
Patrick KullmanPresident and Chief Operating OfficerMay 2016
Randal BetzDirectorMay 2016
Scott HaufeDirectorMay 2016
Steve GorlinCo-ChairmanMay 2016
Thomas HillsDirectorMay 2016